FDA OKs Pfizer drug for rare, fast-killing type of leukemia – New Jersey Herald
New Jersey Herald |
FDA OKs Pfizer drug for rare, fast-killing type of leukemia
New Jersey Herald FILE – In this Monday, Nov. 23, 2015, file photo, a Pfizer flag is displayed in front of the company’s world headquarters in New York. The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer … FDA Approves New Acute Lymphoblastic Leukemia Treatment FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.